GE HealthCare has launched Thera4Care, a groundbreaking initiative designed to transform the application of theranostics and enhance patient accessibility across Europe. The objective of Thera4Care is to promote the development and utilization of theranostic technologies throughout the continent by establishing and implementing standardized and scalable procedures. These methods will cover various stages, from the production and initial delivery of diagnostic tools to therapeutic applications, involving key theranostic isotopes.
The company revealed that this 25.3 million euro project brings together 29 collaborators, including leading European academic institutions, clinical centers, small and medium-sized enterprises, and patient advocacy organizations.
